AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Betahistine Hydrochloride

14 registrations across 1 African market— 12 active

Markets with Betahistine Hydrochloride

🇿🇦South Africa
14 registrations
12 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
TREVIGO 8 mg TABLETS🇿🇦South AfricaNovagen Pharma (Pty) LtdsuspendedNov 2024
TREVIGO 16 mg TABLETS🇿🇦South AfricaNovagen Pharma (Pty) LtdsuspendedNov 2024
VERTIN 16🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJul 2006
DAHIDE 8 mg TABLETS🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
DAHIDE 16 mg TABLETS🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
HIDRIST 8 mg TABLETS🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
HIDRIST 16 mg TABLETS🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
HIDRIST 24 mg TABLETS🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
DAHIDE 24 mg TABLETS🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
VERTIN 24🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
MENIVERT🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
VERTIN 8🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
SERC 24🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
TREVIGO 24 mg TABLETS🇿🇦South AfricaNovagen Pharma (Pty) LtdactiveJan 1900

Betahistine Hydrochloride in Africa — Regulatory Overview

Betahistine Hydrochloride is registered across 1 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 14 registrations, 12 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.